Neuroscience News

Oxytocin signaling may not be responsible for prairie voles’ strong social bonds, including their proclivity for staying close to their mates according to re

Interdisciplinary Postdocs and Brain Resilience Scholars will advance knowledge of brain health and aging.

Rob Malenka answers: "Why are psychiatrists taking a fresh look at MDMA?"

Experts, including Stanford researchers, weigh in on whether the newly approved Alzheimer's treatment lecanemab is worth taking.

Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.

New study builds the foundation for future success against brain decline.

The Phil and Penny Knight Initiative for Brain Resilience is proud to announce the recipients of its inaugural 2022 Innovation and Catalyst Grants.

Knight Initiative researchers report that they identified novel molecular markers capable of tracking the progression of Parkinson’s disease.

Neuroscientist Robert Malenka and his team have identified a molecular link between opioid withdrawal and social aversion in the brains of mice—suggesting the potential to help people in recovery from opioid addiction reconnect with their social support.

Video and audio data gathered by a smartphone game could facilitate earlier diagnosis of autism spectrum disorder and improve treatment.

About 80% of children with autism have trouble sleeping, but whether better sleep could lessen other autism symptoms is unknown. A new grant will help Stanford Medicine scientists find out.

Brain fog isn’t like a hangover or depression. It’s a disorder of executive function that makes basic cognitive tasks absurdly hard.

By studying the independent evolution of the cephalopod nervous system, researchers like Matt McCoy seek to look past the differences to see common features that could teach us fundamental truths about the evolution of intelligence itself.

Tony Wyss-Coray and colleagues have turned up substances in blood that can accelerate or slow down the brain-aging clock. They've identified proteins on blood-vessel surfaces through which some of these molecules can act on the brain, despite the existenc

Robert Malenka’s early research on the molecular mechanisms underlying memory and learning has led to an understanding of their role in psychiatric disorders including addiction, depression and autism spectrum disorder.

A new study by scientists with the Wu Tsai Neurosciences Institute’s NeuroChoice Initiative reveals that relapse may be linked to quite different brain circuits than addiction itself.